Alexandre Brutti

Alexandre Brutti has been a member of the LuCE board since December 2023. He is a LuCE Member representing the NPO Patients En Reseau in France.

His involvement in patient advocacy began in 2021 after being treated for Lung Cancer in 2020; he retired in 2023 from a 38-year career. Throughout his advocacy journey, Alexandre participates in various significant groups and projects, including LuCE, the Patient Advisory Board of the European Project PREVALUNG EU, the GHU APHP Paris Center Patients Committee, and SIRIC CaRPEM (Cancer Research in Personalized Medicine) of the GHU.

Alexandre’s academic background includes a Master’s Degree in engineering, mathematics, science, computing, and humanities from Esigelec School of Engineering. He has accumulated extensive professional experience in IT, PMO, R&D, Mkg, and Operations, notably within the Multimedia-TV Operator Sector in a multinational corporation with a global footprint.

Alexandre has worked with global teams for years, as a result he understands the mindsets and cultures of other regions, enabling effective global communication and understanding.

Alexandre is currently serving as the Chief Technology Officer (CTO) for the services platform of the French NPO Patients En Reseau, actively engaged in patient advocacy initiatives, particularly focusing on lung cancer.

Beyond his patient advocacy roles, Alexandre is actively involved in the GHU APHP Paris Center Patients Committee, affiliated with the largest Paris Comprehensive Cancer Center.

He speaks French (Native), Italian (Native), and English.